Serum lipid profiles and the burden of polyvascular atherosclerosis: a cross-sectional CTA-based study in a Chinese cohort.
Jing Lu, Fa Lin, Jiadi Weng...
https://pubmed.ncbi.nlm.nih.gov/42532457/Actively Recruiting
Led by Beijing Tiantan Hospital · Updated on 2023-09-21
100000
Participants Needed
14
Research Sites
N/A
Total Duration
Researchers are developing a large, multi-center database platform called the brain-heart comorbidity platform to collect and analyze clinical, sample, and imaging data from patients newly diagnosed with various cardiovascular-related diseases. This observational study aims to integrate artificial intelligence into this platform to enhance research on brain-heart comorbid conditions, supported by the National Key Research and Development Program. The platform stores data on a physical server or virtual appliance at participating institutions, connected through a network that allows for data queries and aggregation across centers. The study collects information on patients diagnosed with diseases identified by specific ICD-10-CM codes, including ischemic heart diseases, cardiac arrest, atrial fibrillation, heart failure, aortic diseases, subarachnoid hemorrhage, intracerebral hemorrhage, cerebral infarction, vascular occlusions, cerebral aneurysm, moyamoya disease, and arteriovenous malformations. Participants undergo multi-disciplinary assessments and their data is carefully checked for quality through a standardized process that removes incomplete or inaccurate records. The main outcomes measured include rates of all-cause mortality and cardiovascular events at discharge and 30 days. This ongoing registry enables continuous data collection and evaluation to better understand outcomes for patients with brain-heart comorbidities.
CONDITIONS
Registry of Multicenter Brain-Heart Comorbidity in China
X
Xiaolin Chen, MD
F
Fa Lin, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Beijing Tiantan Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At discharge or within 30 days
Participants undergo multi-disciplinary assessments to evaluate brain-heart comorbidities.
1 to 2 visits depending on assessments
Duration - Up to 30 days after discharge
Participants are monitored for mortality and cardiovascular outcomes after initial evaluation.
Follow-up visits as needed within 30 days
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Jing Lu, Fa Lin, Jiadi Weng...
https://pubmed.ncbi.nlm.nih.gov/42532457/Beijing Tiantan Hospital
Lead Sponsor